Skip to main content
Log in

The role of genetic and autoimmune factors in premature ovarian failure

  • Gonadal Physiology and Disease
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To identify the role of both genetic (number of CGG repeats in the FMR1 gene) and autoimmune factors (anti-ovarian antibodies) in premature ovarian failure (POF).

Methods

In cross-sectional study, 78 women with POF were divided into 3 groups by the number of CGG repeats (less than 28, 28–36, more than 36) in any of the FMR1 gene alleles. We performed the detection of skewed X-chromosome inactivation, CGG repeats in the FMR1 gene, anti-ovarian antibodies (AOA) and sex hormones tests.

Results

Compared to a higher or lower number of CGG repeats the 28–36 triple CGG counts are strongly associated with the AOA detection (RR = 19.23, 95 % CI = 2.63–100.0). The women with autoimmune-driven POF have significantly higher anti-Mullerian hormone levels in comparison to women with non-autoimmune-driven POF.

Conclusion

The presence of AOA above 10 IU/mL is associated with the normal number of CGG repeats in regard to ovarian reserve and a better preservation of follicular primordial pool in the women with POF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation. Am J Hum Genet. 1992;51:1229–39.

    PubMed  CAS  Google Scholar 

  2. Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22(8):2142–52.

    Article  PubMed  CAS  Google Scholar 

  3. Ashrafi M, Fallahian M, Eshrati M, Yazdi RS. The Presence of Anti Thyroid and Anti Ovarian Auto-Antibodies in Familial Premature Ovarian Failure. Int J Fertil Steril. 2008;1(4):171–4.

    Google Scholar 

  4. Chen LS, Tassone F, Sahota P, Hagerman PJ. The CGG repeat element within the 5′ untranslated region of the FMR1 message provides both positive and negative effects on in vivo translation of a downstream reporter. Hum Mol Genet. 2003;12(23):3067–74.

    Article  PubMed  CAS  Google Scholar 

  5. Conway GS, Katlas G, Patel A, Davies MS, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;65(2):337–41.

    PubMed  CAS  Google Scholar 

  6. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998;13(5):1184–7.

    Article  PubMed  CAS  Google Scholar 

  7. Coulam CB, Ryan RJ. Premature menopause.I. Etiology. Am J Obstet Gynecol. 1979;133(6):639–43.

    PubMed  CAS  Google Scholar 

  8. Fenishel P, Sosset C, Barbarino-Monnier P, Gobert B, Hieronimus S, Bene MC, et al. Prevalence, specificity and significance of antiovarian antibodies during spontaneous premature ovarian failure. Hum Reproad. 1997;12(12):2623–8.

    Article  Google Scholar 

  9. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67(6):1047–58.

    Article  PubMed  CAS  Google Scholar 

  10. Gleicher N, Weghofer A, Barad D. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.

    Article  PubMed  Google Scholar 

  11. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing. Reprod Biomed Online. 2010;20(6):768–75.

    Article  PubMed  CAS  Google Scholar 

  12. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009;19(3):385–90.

    Article  PubMed  CAS  Google Scholar 

  13. Gleicher N, Weghofer A, Oktay K, Barad DH. Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause. 2009;16(4):760–4.

    Article  PubMed  Google Scholar 

  14. La Marka A, Marzotti S, Bronzetti A, Stabile G, Artenisio AC, Bini V, et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J Clin Endocrinol Metab. 2009;94(10):3816–23.

    Article  Google Scholar 

  15. Sato K, Uehara S, Hashiyada M, Nabeshima H, Sugawara J, Terada Y, et al. Genetic significance of skewed X-chromosome inactivation in premature ovarian failure. Am J Med Genet. 2004;130A(3):240–4.

    Article  PubMed  Google Scholar 

  16. Shamilova NN, Marchenko LA, Shamilova NN, Marchenko LA. The FMR1 gene: new possibilities of assessing the ovarian reserve. Akusherstvo & Gynecologiya. 2011;2:58–64. article in Russian.

    Google Scholar 

  17. Sugawa F, Wada Y, Maruyama T, Uchida H, Ishizuka B, Ogata T. Premature ovarian failure and androgen receptor gene CAG repeat lengths weighted by X chromosome inactivation patterns. Fertil Steril. 2009;91(2):649–52.

    Article  PubMed  CAS  Google Scholar 

  18. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–12.

    Article  PubMed  CAS  Google Scholar 

  19. Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab. 2008;93(4):1263–9.

    Article  PubMed  CAS  Google Scholar 

  20. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68(4):499–509.

    Article  Google Scholar 

  21. Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod. 1997;12(12):2617–22.

    Article  PubMed  CAS  Google Scholar 

  22. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87(3):456–65.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Funding for this study was provided by Ministry of Health of the Russian Federation (grant # 2010-06 reg. #01201066000).

The authors thank Tatyana Y. Ivanets, M.D., Ph.D., the Chief of Scientific-Diagnostic Laboratory of the RCOGP for the assistance in the implementation of the study.

Declaration

The authors report no financial or commercial conflicts of interest

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nataliya V. Dolgushina.

Additional information

Capsule

Detection of anti-ovarian antibodies is associated with the normal number of CGG repeats in regard to ovarian reserve and a better preservation of follicular primordial pool in the women with premature ovarian failure.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shamilova, N.N., Marchenko, L.A., Dolgushina, N.V. et al. The role of genetic and autoimmune factors in premature ovarian failure. J Assist Reprod Genet 30, 617–622 (2013). https://doi.org/10.1007/s10815-013-9974-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-013-9974-4

Keywords

Navigation